Bilaketaren emaitzak - Ming‐Lung Yu

Findu emaitzak
  1. 1
    Treatment of chronic hepatitis C in Asia: When East meets West

    Treatment of chronic hepatitis C in Asia: When East meets West nork Ming‐Lung Yu, Wan‐Long Chuang

    Argitaratua 2009
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy

    Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy nork Chung‐Feng Huang, Ming‐Lung Yu

    Argitaratua 2020
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Reply to the comment on “High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C”

    Reply to the comment on “High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C” nork Yen‐Chun Chen, Ming‐Lung Yu

    Argitaratua 2025
    Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Hepatitis B reactivation during or after direct acting antiviral therapy – implication for susceptible individuals

    Hepatitis B reactivation during or after direct acting antiviral therapy – implication for susceptible individuals nork Jacinta A. Holmes, Ming‐Lung Yu, Raymond T. Chung

    Argitaratua 2017
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular carcinoma undergoing interferon-free therapy: Issue of the interval between HCC treatment and antiviral therapy

    Unexpected early tumor recurrence in patients with hepatitis C virus-related hepatocellular carcinoma undergoing interferon-free therapy: Issue of the interval between HCC treatmen... nork Pei‐Chien Tsai, Chung‐Feng Huang, Ming‐Lung Yu

    Argitaratua 2016
    Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication

    Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication nork Chung‐Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming‐Lung Yu

    Argitaratua 2024
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  7. 7
    MAFLD: an ideal framework for understanding disease phenotype in individuals of normal weight

    MAFLD: an ideal framework for understanding disease phenotype in individuals of normal weight nork Ziyan Pan, Maryam Al Khatry, Ming‐Lung Yu, Ashok Choudhury, Giada Sebastiani, Saleh A. Alqahtani, Mohammed Eslam

    Argitaratua 2024
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population

    IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population nork Qiong Huang, Ji‐Ye Yin, Xingping Dai, Qi Pei, Min Dong, Zhiguang Zhou, Xi Huang, Ming‐Lung Yu, Hong‐Hao Zhou, Zhaoqian Liu

    Argitaratua 2010
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Hepatitis C Virus Infection Increases Risk of Developing End-Stage Renal Disease Using Competing Risk Analysis

    Hepatitis C Virus Infection Increases Risk of Developing End-Stage Renal Disease Using Competing Risk Analysis nork Jia‐Jung Lee, Ming‐Yen Lin, Jung‐San Chang, Chi‐Chih Hung, Jer‐Ming Chang, Hung‐Chun Chen, Ming‐Lung Yu, Shang‐Jyh Hwang

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Differentiation-Dependent Interactions between RUNX-1 and FLI-1 during Megakaryocyte Development

    Differentiation-Dependent Interactions between RUNX-1 and FLI-1 during Megakaryocyte Development nork Hui Huang, Ming‐Lung Yu, Thomas E. Akie, Tyler B. Moran, Andrew J. Woo, Nathan Tu, Zachary Waldon, Yin Lin, Hanno Steen, Alan Cantor

    Argitaratua 2009
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Systematic review with meta‐analysis: extrahepatic manifestations in chronic hepatitis C virus‐infected patients in East Asia

    Systematic review with meta‐analysis: extrahepatic manifestations in chronic hepatitis C virus‐infected patients in East Asia nork Zobair M. Younossi, Linda Henry, Janus P. Ong, Atsushi Tanaka, Yuichiro Eguchi, Masashi Mizokami, Young‐Suk Lim, Yock Young Dan, Ming‐Lung Yu, Maria Stepanova

    Argitaratua 2019
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C

    Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C nork Hsieh Mc, Ming‐Lung Yu, Wan‐Long Chuang, SJ Shin, CY Dai, Shuo Chen, Z-Y. Lin, MY Hsieh, JF Liu, Ling‐Yu Wang, Chang Wy

    Argitaratua 2000
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    The impact of hepatitis C virus outside the liver: Evidence from Asia

    The impact of hepatitis C virus outside the liver: Evidence from Asia nork Zobair M. Younossi, Atsushi Tanaka, Yuichiro Eguchi, Young‐Suk Lim, Ming‐Lung Yu, Norifumi Kawada, Yock Young Dan, C. Brooks-Rooney, Francesco Negro, Mario U. Mondelli

    Argitaratua 2016
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Viral Interaction and Responses in Chronic Hepatitis C and B Coinfected Patients with Interferon-Alpha plus Ribavirin Combination Therapy

    Viral Interaction and Responses in Chronic Hepatitis C and B Coinfected Patients with Interferon-Alpha plus Ribavirin Combination Therapy nork Wan‐Long Chuang, Chia‐Yen Dai, Wen‐Yu Chang, Li‐Po Lee, Zu‐Yau Lin, Shinn‐Cherng Chen, Ming‐Yuh Hsieh, Liang‐Yen Wang, Ming‐Lung Yu

    Argitaratua 2005
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    The first case of monkeypox virus infection detected in Taiwan: awareness and preparation

    The first case of monkeypox virus infection detected in Taiwan: awareness and preparation nork Zih‐Syuan Yang, C. C. Lin, Aspiro Nayim Urbina, Wen‐Hung Wang, Wanchai Assavalapsakul, Sung‐Pin Tseng, Po‐Liang Lu, Yen‐Hsu Chen, Ming‐Lung Yu, Sheng‐Fan Wang

    Argitaratua 2022
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Significant correlations between severe fatty liver and risk factors for metabolic syndrome

    Significant correlations between severe fatty liver and risk factors for metabolic syndrome nork Pi‐Jung Hsiao, Kung‐Kai Kuo, Shyi–Jang Shin, Yi‐Hsin Yang, Wen‐Yi Lin, Jeng‐Fu Yang, Chao‐Chin Chiu, Wan‐Long Chuang, Tong‐Rong Tsai, Ming‐Lung Yu

    Argitaratua 2006
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Association of Dialysis with the Risks of Cancers

    Association of Dialysis with the Risks of Cancers nork Ming‐Yen Lin, Mei Chuan Kuo, Chi-Chih Hung, Wen‐Jeng Wu, Li Tzong Chen, Ming‐Lung Yu, Chih‐Cheng Hsu, Chien‐Hung Lee, Hung‐Chun Chen, Shang‐Jyh Hwang

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Diagnostic Value of Immunoglobulin G (IgG) and IgM Anti-Hepatitis E Virus (HEV) Tests Based on HEV RNA in an Area Where Hepatitis E Is Not Endemic

    Diagnostic Value of Immunoglobulin G (IgG) and IgM Anti-Hepatitis E Virus (HEV) Tests Based on HEV RNA in an Area Where Hepatitis E Is Not Endemic nork Chen‐Chun Lin, Jaw‐Ching Wu, Ting‐Tsung Chang, Wen‐Yu Chang, Ming‐Lung Yu, Albert W. Tam, Shen-Chin Wang, Yi‐Hsiang Huang, Full‐Young Chang, Shou‐Dong Lee

    Argitaratua 2000
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    A Sustained Virological Response to Interferon or Interferon/Ribavirin Reduces Hepatocellular Carcinoma and Improves Survival in Chronic Hepatitis C: A Nationwide, Multicentre Study in Taiwan

    A Sustained Virological Response to Interferon or Interferon/Ribavirin Reduces Hepatocellular Carcinoma and Improves Survival in Chronic Hepatitis C: A Nationwide, Multicentre Stud... nork Ming‐Lung Yu, Shi‐Ming Lin, Wan‐Long Chuang, Chia‐Yen Dai, Jing‐Houng Wang, Sheng‐Nan Lu, I‐Shyan Sheen, Wen‐Yu Chang, Chuan–Mo Lee, Yun–Fan Liaw

    Argitaratua 2006
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resection

    Impact of tumor size on the prognosis of hepatocellular carcinoma in patients who underwent liver resection nork Chia‐Yen Dai, Ching‐Yeh Lin, Pei‐Chien Tsai, Ping‐Yi Lin, Ming‐Lun Yeh, Chung‐Feng Huang, Wen‐Tsan Chang, Jee‐Fu Huang, Ming‐Lung Yu, Yao‐Li Chen

    Argitaratua 2017
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: